Pineapple Financial Bets $100M on Blockchain's Next Frontier

Injective (INJ) has gained significant institutional traction with the launch of a $100 million digital asset treasury by Pineapple Financial, a publicly traded fintech company listed on the NYSE American (PAPL). The treasury, funded through a private placement, is the first of its kind for a publicly traded firm to allocate capital directly to INJ tokens. According to the firm's press release, the treasury is expected to yield approximately 12% annually through staking, positioning it among the most lucrative digital asset allocations in the blockchain sector [1].

The strategic move has positioned Injective as a focal point in the ongoing institutional adoption of blockchain assets, especially amid evolving regulatory landscapes in the U.S. The U.S. Securities and Exchange Commission (SEC) has recently opened a 21-day public comment period on a staked INJ ETF application by Canary Capital, which has added further momentum to the token’s institutional appeal [1]. This development follows a broader trend of corporate treasury allocations into digital assets, with firms like Sharplink Gaming and Bitmine acquiring substantial amounts of Ethereum and Bitcoin, respectively [1].

Injective’s price has also shown notable movement in the wake of the treasury announcement. As of recent reporting, INJ has stabilized around the $12.8 level, slightly off its intraday high of $13.2 following the news. The token had previously seen a 14% decline over a three-day period in late August, though recent technical indicators suggest easing sell-side pressure. The Moving Average Convergence Divergence (MACD) histogram remains in negative territory, but the MACD line is showing signs of a potential bullish crossover with the signal line, which could indicate renewed buying interest [1].

On-chain activity for the Injective network has also shown substantial growth, with the network’s daily active user base surpassing 78,500 as of mid-August 2025. This represents a 1,460% increase since the beginning of the year, highlighting the growing utility and adoption of the platform. Analysts note that the increased user activity could provide long-term support for the token’s price as demand for the network’s decentralized finance (DeFi) infrastructure continues to expand [1].

The broader market context for INJ is also favorable, with real-world asset (RWA) tokens gaining traction among investors. Injective has emerged as a key player in this space, alongside Provenance and Stellar. The firm’s strategic alignment with institutional-grade infrastructure and growing regulatory clarity has helped attract a diverse range of investors, including FalconX, Monarq, and the Injective Foundation [2]. This institutional interest is expected to continue as the ecosystem expands and more tokenized assets are integrated onto the Injective chain.

Pineapple Financial’s initiative marks a pivotal moment for Injective and the broader blockchain ecosystem. By offering a structured and transparent vehicle for institutional exposure to INJ, the firm is bridging the gap between traditional finance and the decentralized world. As regulatory frameworks mature and more firms consider digital asset allocations, the role of platforms like Injective in facilitating these transitions is likely to grow. The $100 million treasury represents not just a financial investment, but also a strategic signal of confidence in the long-term viability of the Injective ecosystem and its underlying technology [1].

Source:

[1] Pineapple Financial Launches First Corporate Injective (INJ) Treasury (Yahoo Finance) [https://finance.yahoo.com]

[2] Injective (INJ) Hits Wall Street With $100M Public Treasury Launch (99Bitcoins) [https://99bitcoins.com]